|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/06/15 Solarcity Corp 10-Q 3/31/15 89:20M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 933K
2: EX-4.11 EX-4.11 Indenture HTML 584K
3: EX-10.16C EX-10.16C Third Amendment HTML 34K
4: EX-10.16D EX-10.16D Fourth Amendment HTML 35K
5: EX-10.17A EX-10.17A Standard Definitions HTML 189K
6: EX-10.17B EX-10.17B Note Purchase Agreement HTML 251K
7: EX-10.18 EX-10.18 Credit Agreement HTML 621K
8: EX-31.1 EX-31.1 CEO Certification HTML 33K
9: EX-31.2 EX-31.2 CFO Certification HTML 32K
10: EX-32.1 EX-32.1 CEO Certification HTML 28K
11: EX-32.2 EX-32.2 CFO Certification HTML 28K
62: R1 Document and Entity Information HTML 49K
49: R2 Condensed Consolidated Balance Sheets HTML 205K
60: R3 Condensed Consolidated Balance Sheets HTML 128K
(Parenthetical)
64: R4 Condensed Consolidated Statements of Operations HTML 116K
(Unaudited)
83: R5 Condensed Consolidated Statements of Cash Flows HTML 175K
51: R6 Organization HTML 33K
59: R7 Summary of Significant Accounting Policies and HTML 171K
Procedures
45: R8 Goodwill and Intangible Assets HTML 299K
35: R9 Selected Balance Sheet Components HTML 158K
84: R10 Indebtedness HTML 387K
66: R11 VIE Arrangements HTML 231K
65: R12 Financing Obligations HTML 36K
71: R13 Redeemable Noncontrolling Interests in HTML 43K
Subsidiaries
72: R14 Equity HTML 82K
69: R15 Equity Award Plans HTML 201K
73: R16 Income Taxes HTML 36K
61: R17 Related Party Transactions HTML 70K
63: R18 Commitments and Contingencies HTML 53K
68: R19 Basic and Diluted Net Loss Per Share HTML 77K
89: R20 Subsequent Events HTML 33K
79: R21 Summary of Significant Accounting Policies and HTML 205K
Procedures (Policies)
55: R22 Summary of Significant Accounting Policies and HTML 148K
Procedures (Tables)
67: R23 Goodwill and Intangible Assets (Tables) HTML 297K
57: R24 Selected Balance Sheet Components (Tables) HTML 158K
26: R25 Indebtedness (Tables) HTML 352K
80: R26 VIE Arrangements (Tables) HTML 226K
86: R27 Redeemable Noncontrolling Interests in HTML 40K
Subsidiaries (Tables)
40: R28 Equity (Tables) HTML 75K
39: R29 Equity Award Plans (Tables) HTML 202K
43: R30 Related Party Transactions (Tables) HTML 67K
44: R31 Basic and Diluted Net Loss Per Share (Tables) HTML 78K
46: R32 Organization - Additional Information (Detail) HTML 29K
24: R33 Summary of Significant Accounting Policies and HTML 96K
Procedures - Additional Information (Detail)
77: R34 Summary of Significant Accounting Policies and HTML 57K
Procedures - Fair Value of Company's Cash
Equivalents, Short-Term Investments and Contingent
Consideration (Detail)
53: R35 Summary of Significant Accounting Policies and HTML 34K
Procedures - Summary of the Activity of the Level
3 Contingent Consideration (Detail)
56: R36 Summary of Significant Accounting Policies and HTML 37K
Procedures - Schedule of Estimated Fair Values
(Detail)
29: R37 Summary of Significant Accounting Policies and HTML 37K
Procedures - Summary of MyPower Deferred Revenue
Activity (Detail)
88: R38 Summary of Significant Accounting Policies and HTML 34K
Procedures - Summary of MyPower Deferred Cost
Activity (Detail)
18: R39 Summary of Significant Accounting Policies and HTML 30K
Procedures - Summary of MyPower Deferred Cost
Activity (Parenthetical) (Detail)
47: R40 Summary of Significant Accounting Policies and HTML 37K
Procedures - Schedule of Changes in Accrued
Warranty Balance (Detail)
82: R41 Goodwill and Intangible Assets - Summary of HTML 89K
Intangible Assets (Detail)
28: R42 Goodwill and Intangible Assets - Amortization HTML 44K
Expense for Identifiable Purchased Intangible
Assets (Detail)
38: R43 Goodwill and Intangible Assets - Additional HTML 33K
Information (Detail)
42: R44 Goodwill and Intangible Assets - Summary of HTML 59K
Expected Future Amortization Expense for
Intangible Assets (Detail)
50: R45 Selected Balance Sheet Components - Components of HTML 119K
Condensed Consolidated Balance Sheet (Detail)
23: R46 Selected Balance Sheet Components - Components of HTML 38K
Condensed Consolidated Balance Sheet
(Parenthetical) (Detail)
34: R47 Indebtedness - Summary of Debt (Detail) HTML 177K
20: R48 Indebtedness - Additional Information (Detail) HTML 248K
81: R49 VIE Arrangements - Summary of Number of Current HTML 64K
VIE Funds by Classification of Investor, the
Carrying Value, Total Investor Contributions
Received and Undrawn Investor Contributions
(Detail)
27: R50 VIE Arrangements - Additional Information (Detail) HTML 42K
78: R51 VIE Arrangements - Carrying Values of Assets and HTML 148K
Liabilities of Subsidiary in Consolidated Balance
Sheets (Detail)
30: R52 Financing Obligations - Additional Information HTML 33K
(Detail)
48: R53 Redeemable Noncontrolling Interests in HTML 47K
Subsidiaries - Activity of Redeemable
Noncontrolling Interests in Subsidiaries (Detail)
19: R54 Equity - Schedule of Changes in Total HTML 59K
Stockholders' Equity and Noncontrolling Interests
(Detail)
22: R55 Equity Award Plans - Additional Information HTML 77K
(Detail)
41: R56 Equity Award Plans - Summary of Stock Option HTML 87K
Activity (Detail)
25: R57 Equity Award Plans - Summary of Stock Option HTML 30K
Activity (Parenthetical) (Detail)
85: R58 Equity Award Plans - Summary of Fair Value of HTML 41K
Stock Options Granted Using Weighted-Average
Assumptions (Detail)
52: R59 Equity Award Plans - Summary of RSU Activity HTML 59K
(Detail)
70: R60 Equity Award Plans - Summary of Stock-Based HTML 42K
Compensation Expense Capitalized (Detail)
33: R61 Equity Award Plans - Summary of Stock-Based HTML 44K
Compensation Expense Recognized (Detail)
36: R62 Income Taxes - Additional Information (Detail) HTML 40K
76: R63 Related Party Transactions - Components of Related HTML 35K
Party Transactions (Detail)
74: R64 Related Party Transactions - Summary of Related HTML 46K
Party Balances (Detail)
54: R65 Commitments and Contingencies - Additional HTML 73K
Information (Detail)
75: R66 Basic and Diluted Net Loss Per Share - Computation HTML 56K
of Company's Basic and Diluted Net Loss Per Share
(Detail)
31: R67 Basic and Diluted Net Loss Per Share - Schedule of HTML 42K
Weighted-Average Outstanding Shares of Common
Stock Equivalents Excluded from Computation of
Diluted Net Loss Per Share (Detail)
58: R68 Subsequent Events - Additional Information HTML 73K
(Detail)
87: XML IDEA XML File -- Filing Summary XML 134K
21: EXCEL IDEA Workbook of Financial Reports XLSX 208K
37: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 3.38M
12: EX-101.INS XBRL Instance -- scty-20150331 XML 4.07M
14: EX-101.CAL XBRL Calculations -- scty-20150331_cal XML 237K
15: EX-101.DEF XBRL Definitions -- scty-20150331_def XML 745K
16: EX-101.LAB XBRL Labels -- scty-20150331_lab XML 1.38M
17: EX-101.PRE XBRL Presentations -- scty-20150331_pre XML 1.09M
13: EX-101.SCH XBRL Schema -- scty-20150331 XSD 215K
32: ZIP XBRL Zipped Folder -- 0001564590-15-003352-xbrl Zip 217K
Exhibit 10.16c
THIRD AMENDMENT TO AMENDED AND RESTATED AGREEMENT FOR RESEARCH & DEVELOPMENT ALLIANCE ON
TRIEX MODULE TECHNOLOGY
This THIRD AMENDMENT TO AMENDED AND RESTATED AGREEMENT FOR RESEARCH & DEVELOPMENT ALLIANCE ON TRIEX MODULE TECHNOLOGY (this “Amendment”) is effective as of February 12, 2015 (the “Effective Date”) and is by and between THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (“FOUNDATION”), a non-profit educational corporation existing under the laws of the State of New York, having an office located at 257 Fuller Road, Albany, New York 12203, on behalf of the Colleges of Nanoscale Science and Engineering of the State University of New York Polytechnic Institute), and SILEVO, INC. (“SILEVO”), a Delaware corporation with its principal office located at 45655 Northport Loop East, Fremont, California 94555. FOUNDATION and SILEVO are each referred to herein sometimes individually as a “Party” or, collectively, as “Parties.”
I. RECITALS
I.1. FOUNDATION and SILEVO entered into that certain Amended and Restated Agreement for Research & Development Alliance on Triex Module Technology effective as of September 2, 2014, as amended by a First Amendment thereto effective as of October 31, 2014 and a Second Amendment thereto effective as of December 15, 2014 (as amended, the “Agreement”)
I.2. The parties wish to amend the terms of Section 19.14 of the Agreement as set forth in this Amendment.
THEREFORE, in consideration of the mutual promises and covenants contained in this Amendment and other good and valuable consideration, the receipt and sufficiency of which hereby are acknowledged, and intending to be legally bound hereby, the Parties agree as follows:
II. DEFINED TERMS
In addition to the terms defined elsewhere in this Amendment, capitalized terms that are used but not defined herein shall have the meanings ascribed to such terms in the Agreement.
III. AMENDMENTS
Section 19.14 is amended by deleting the reference to “February 13, 2015” and replacing it with “March 31, 2015”.
IV. MISCELLANEOUS
No amendment or modification of this Amendment shall be valid or binding upon the Parties unless in a writing executed by both of the Parties. This Amendment, together with the Agreement, is the complete and exclusive statement of the agreement of the Parties in respect of the subject matter described in this Amendment and shall supersede all prior and contemporaneous agreements, communications, representations, and understandings, either oral or written, between the Parties or any officers, agents or representatives thereof. This Amendment may be signed in one or
more counterparts, each of which shall be deemed to be an original and all of which when taken together shall constitute the same Amendment. Any signed copy of this Amendment made by photocopy, facsimile or PDF Adobe format shall be considered an original. Except as amended and/or modified by this Amendment, the Agreement is hereby ratified and confirmed and the Agreement and all other terms thereof shall remain in full force and effect, unaltered and unchanged by this Amendment. In the event of any conflict between the provisions of this Amendment and the provisions of the Agreement, the provisions of this Amendment shall prevail. Whether or not specifically amended by this Amendment, all of the terms and provisions of the Agreement are hereby amended to the extent necessary to give effect to the purpose and intent of this Amendment.
IN WITNESS WHEREOF, the Parties hereto have caused this Amendment to be executed and delivered by their duly authorized representatives as of the Effective Date.
THE RESEARCH FOUNDATION FOR
THE STATE UNIVERSITY OF NEW YORK
By: /s/ Christine Waller
Name: Christine Waller
Title: Operations Manager
SILEVO, INC.
By: /s/ Lyndon Rive
Name: Lyndon Rive
Title: President
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/6/15 | |||
| For Period end: | 3/31/15 | 424B5, 8-K, CT ORDER, FWP | ||
| 2/13/15 | SC 13D/A | |||
| 2/12/15 | ||||
| 12/15/14 | ||||
| 10/31/14 | ||||
| 9/2/14 | 4 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/29/24 Tesla, Inc. 10-K 12/31/23 116:14M Workiva Inc Wde… FA01/FA 1/31/23 Tesla, Inc. 10-K 12/31/22 125:30M Donnelley … Solutions/FA 5/02/22 Tesla, Inc. 10-K/A 12/31/21 12:2.6M ActiveDisclosure/FA 2/07/22 Tesla, Inc. 10-K 12/31/21 131:28M Donnelley … Solutions/FA 4/30/21 Tesla, Inc. 10-K/A 12/31/20 12:2.3M ActiveDisclosure/FA 2/08/21 Tesla, Inc. 10-K 12/31/20 149:31M ActiveDisclosure/FA |